EA202192344A1 - Тритерпеноидные фунгициды для лечения или предотвращения пневмоцистной пневмонии, вызванной pneumocystis spp - Google Patents
Тритерпеноидные фунгициды для лечения или предотвращения пневмоцистной пневмонии, вызванной pneumocystis sppInfo
- Publication number
- EA202192344A1 EA202192344A1 EA202192344A EA202192344A EA202192344A1 EA 202192344 A1 EA202192344 A1 EA 202192344A1 EA 202192344 A EA202192344 A EA 202192344A EA 202192344 A EA202192344 A EA 202192344A EA 202192344 A1 EA202192344 A1 EA 202192344A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- prevention
- treatment
- triterpenoid
- pneumocystis spp
- pneumocystispneumonia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811456P | 2019-02-27 | 2019-02-27 | |
| PCT/US2020/019724 WO2020176527A1 (en) | 2019-02-27 | 2020-02-25 | Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202192344A1 true EA202192344A1 (ru) | 2021-11-15 |
Family
ID=70005768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202192344A EA202192344A1 (ru) | 2019-02-27 | 2020-02-25 | Тритерпеноидные фунгициды для лечения или предотвращения пневмоцистной пневмонии, вызванной pneumocystis spp |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12594266B2 (https=) |
| EP (1) | EP3930716B1 (https=) |
| JP (1) | JP7581219B2 (https=) |
| KR (1) | KR20210133241A (https=) |
| CN (1) | CN113631165A (https=) |
| AU (1) | AU2020228036B2 (https=) |
| BR (1) | BR112021016876A2 (https=) |
| CA (1) | CA3131298A1 (https=) |
| EA (1) | EA202192344A1 (https=) |
| ES (1) | ES3055272T3 (https=) |
| IL (1) | IL285839A (https=) |
| MA (1) | MA55081A (https=) |
| MX (2) | MX2021010311A (https=) |
| TW (1) | TWI910099B (https=) |
| WO (1) | WO2020176527A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK173802B1 (da) * | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
| US5166135A (en) * | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| DK2007396T3 (da) | 2006-04-03 | 2013-03-18 | Merck Sharp & Dohme | Enfumafungin-derivat som antimykotika |
| US8188085B2 (en) | 2008-08-12 | 2012-05-29 | Merck Sharp & Dohme Corp. | Antifungal agents |
| CN108883152A (zh) * | 2016-01-08 | 2018-11-23 | 奇达拉治疗公司 | 防止和治疗肺孢子虫感染的方法 |
| EP3609539A1 (en) * | 2017-04-10 | 2020-02-19 | Scynexis, Inc. | Antifungal agents used in combination |
| EP4732902A2 (en) * | 2017-08-04 | 2026-04-29 | Scynexis, Inc. | Antifungal agents with enhanced activity in acidic ph |
-
2020
- 2020-02-25 MA MA055081A patent/MA55081A/fr unknown
- 2020-02-25 MX MX2021010311A patent/MX2021010311A/es unknown
- 2020-02-25 US US17/432,926 patent/US12594266B2/en active Active
- 2020-02-25 ES ES20714386T patent/ES3055272T3/es active Active
- 2020-02-25 WO PCT/US2020/019724 patent/WO2020176527A1/en not_active Ceased
- 2020-02-25 BR BR112021016876A patent/BR112021016876A2/pt unknown
- 2020-02-25 CA CA3131298A patent/CA3131298A1/en active Pending
- 2020-02-25 AU AU2020228036A patent/AU2020228036B2/en active Active
- 2020-02-25 CN CN202080023125.XA patent/CN113631165A/zh active Pending
- 2020-02-25 EA EA202192344A patent/EA202192344A1/ru unknown
- 2020-02-25 EP EP20714386.8A patent/EP3930716B1/en active Active
- 2020-02-25 KR KR1020217030157A patent/KR20210133241A/ko active Pending
- 2020-02-25 JP JP2021549801A patent/JP7581219B2/ja active Active
- 2020-02-27 TW TW109106501A patent/TWI910099B/zh active
-
2021
- 2021-08-24 IL IL285839A patent/IL285839A/en unknown
- 2021-08-26 MX MX2025004197A patent/MX2025004197A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020176527A1 (en) | 2020-09-03 |
| US12594266B2 (en) | 2026-04-07 |
| TWI910099B (zh) | 2026-01-01 |
| MX2025004197A (es) | 2025-09-02 |
| KR20210133241A (ko) | 2021-11-05 |
| MA55081A (fr) | 2022-01-05 |
| CA3131298A1 (en) | 2020-09-03 |
| US20230149376A1 (en) | 2023-05-18 |
| AU2020228036A1 (en) | 2021-09-23 |
| EP3930716A1 (en) | 2022-01-05 |
| JP2022523212A (ja) | 2022-04-21 |
| TW202045169A (zh) | 2020-12-16 |
| IL285839A (en) | 2021-10-31 |
| JP7581219B2 (ja) | 2024-11-12 |
| ES3055272T3 (en) | 2026-02-10 |
| AU2020228036B2 (en) | 2025-08-07 |
| MX2021010311A (es) | 2022-01-04 |
| CN113631165A (zh) | 2021-11-09 |
| EP3930716B1 (en) | 2025-09-10 |
| BR112021016876A2 (pt) | 2021-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA522433000B1 (ar) | مركبات فلورو ألكيل-أوكساديازول واستخداماتها | |
| MX2022011804A (es) | Uso de agentes para el tratamiento de condiciones respiratorias. | |
| ECSP12012004A (es) | Método de tratamiento de la fibrilación auricular | |
| NO20073774L (no) | Terapeutiske forbindelser for intranasal administrering av ketorolac | |
| MX2023012875A (es) | Inhibidores 2-fluoro alquil-l,3,4-oxadiazol-5-il-tiazol de hdac6 para su uso en el tratamiento de enfermedades metabólicas y hfpef. | |
| CO2022016153A2 (es) | Inhibidores de il4i1 y métodos de uso | |
| MX2024009444A (es) | Métodos de tratamiento para la fibrosis quística | |
| MX2023013225A (es) | Inhibidores de la cinasa 4 similar a polo. | |
| PH12023550780A1 (en) | Line-1 inhibitors to treat disease | |
| MX2022003845A (es) | Tratamientos cognitivos medicinales. | |
| JOP20240269A1 (ar) | حلقات كبيرة من إندازول و استخدامها | |
| MX2024002409A (es) | Terapias contra el cancer. | |
| AR127165A1 (es) | Resmetirom para reducir el volumen del hígado | |
| WO2019010301A8 (en) | Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap) | |
| MX2022012001A (es) | Tratamiento preventivo de la migra?a. | |
| EA202192344A1 (ru) | Тритерпеноидные фунгициды для лечения или предотвращения пневмоцистной пневмонии, вызванной pneumocystis spp | |
| MX2021011289A (es) | Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas. | |
| MX2023014898A (es) | Terapia combinada anti-vhc ventajosa. | |
| EA202090445A1 (ru) | ПРОТИВОГРИБКОВЫЕ СРЕДСТВА С ПОВЫШЕННОЙ АКТИВНОСТЬЮ ПРИ КИСЛОМ pH | |
| WO2020101790A3 (en) | Methods of using a phenoxypropylamine compound to treat pain | |
| CL2021003303A1 (es) | Tratamiento para sinucleinopatías. | |
| JOP20210221A1 (ar) | علاجات مشتركة لاستخدامها في علاج السرطان | |
| MX2019012116A (es) | Agentes antifungicos utilizados en combinacion. | |
| EA202192107A1 (ru) | Тритерпеноидные фунгициды для лечения грибковых костно-суставных инфекций | |
| EA202191415A1 (ru) | Комбинированная терапия, включающая ингибитор krasg12c и одно или несколько дополнительных фармацевтически активных средств, для лечения видов рака |